Search Results 921-930 of 18604 for hepatitis

  1. APOLLO: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis - Mayo Clinic

    Have negative serology for hepatitis B virus (HBV) and hepatitis C virus (HCV). Exclusion Criteria: Had a prior liver transplant or is planned to undergo ...

  2. Focal segmental glomerulosclerosis (FSGS) - Symptoms and causes - Mayo Clinic

    These include diabetes, lupus, obesity and other kidney diseases. Certain infections. Infections that increase the risk of FSGS include HIV and hepatitis C.

  3. Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis - Mayo Clinic

    * Active hepatitis due to hepatitis B virus or hepatitis C virus * Known history or presence of venous thromboembolism/venous thrombotic events (deep vein ...

  4. Mayo Clinic Transplant Center - Doctors

    Liver transplant, Nonalcoholic fatty liver disease, Alcoholic hepatitis, Hepatocellular carcinoma, Gallbladder cancer, ...Cholestasis of pregnancy, Hepatic ...

  5. Diarrhea - Symptoms and causes - Mayo Clinic

    ... hepatitis. Rotavirus is a common cause of sudden childhood diarrhea. The virus that causes coronavirus disease 2019 (COVID-19) also has been linked to ...

  6. A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 In Healthy Participants And Participants With Mild-to-Moderate Asthma - Mayo Clinic

    * Positive human immunodeficiency virus (HIV) antibodies, hepatitis B core antigen, hepatitis B core antibody, or hepatitis C virus (HCV) ribonucleic acid (RNA) ...

  7. Digestive Diseases Videos - Medical Professionals - Mayo Clinic

    Advancements at Mayo Clinic – Hepatitis C is no longer a barrier to transplant. Bashar A. Aqel, M.D., a transplant hepatologist at Mayo Clinic in Arizona ...

  8. Publications - Jennifer L. Horsley-Silva, M.D. - Mayo Clinic

    New Therapies for Hepatitis C Virus Infection. ... Educational Intervention in Primary Care Residents' Knowledge and Performance of Hepatitis B Vaccination in ...

  9. A Study to Assess Safety and Effectiveness of Venetoclax in Combination With Gilteritinib in Subjects With Relapsed/Refractory Acute Myeloid Leukemia - Mayo Clinic

    ... hepatitis B, or hepatitis C. Note: HIV and hepatitis B or C testing is not required and subjects with serologic evidence of prior vaccination to hepatitis ...

  10. Cholangiocarcinoma (bile duct cancer) - Doctors and departments - Mayo Clinic

    ... hepatitis, Hepatocellular carcinoma, Hepatopulmonary syndrome, Primary biliary cholangitis, Hepatitis infectious disease, Acute liver failure. Show more ...